ChemicalBook >> CAS DataBase List >>Durvalumab
Durvalumab
- CAS No.
- 1428935-60-7
- Chemical Name:
- Durvalumab
- Synonyms
- MEDI4736;Durvalumab;Research Grade Durvalumab(DHJ70102)
- CBNumber:
- CB82744216
- Molecular Formula:
- Molecular Weight:
- 0
- MDL Number:
- MFCD00282384
- MOL File:
- Mol file
Last updated:2024-07-02 08:55:23
| storage temp. | Store at 4°C, do not freeze |
|---|---|
| solubility | Soluble in DMSO |
| form | Liquid |
| color | Colorless to light yellow |
| FDA UNII | 28X28X9OKV |
| NCI Dictionary of Cancer Terms | durvalumab |
| NCI Drug Dictionary | durvalumab |
| ATC code | L01XC28 |
Durvalumab price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| ChemScene | CS-0030858 | Durvalumab 99.60% | 1428935-60-7 | 1mg | $280 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | API0018422 | MEDI-4736 95.00% | 1428935-60-7 | 5MG | $504.9 | 2021-12-16 | Buy |
| ChemScene | CS-0030858 | Durvalumab 99.60% | 1428935-60-7 | 5mg | $670 | 2021-12-16 | Buy |
| ChemScene | CS-0030858 | Durvalumab 99.60% | 1428935-60-7 | 25mg | $2550 | 2021-12-16 | Buy |
| ChemScene | CS-0030858 | Durvalumab 99.60% | 1428935-60-7 | 50mg | $4080 | 2021-12-16 | Buy |
Durvalumab Chemical Properties,Uses,Production
Uses
Durvalumab is used to treat non-small cell lung cancer (NSCLC) that spread to nearby tissues and cannot be removed by surgery but has not worsened after being treated with other chemotherapy medications and radiation treatments. Durvalumab injection is also used in combination with etoposide (Etopophos) and either carboplatin or cisplatin to treat extensive-stage small cell lung cancer (ES-SCLC) in adults whose cancer has spread throughout the lungs and to other parts of the body.
Side effects
swelling of your arms or legs;constipation;hair loss
Durvalumab Preparation Products And Raw materials
Raw materials
Preparation Products
Durvalumab Suppliers
Global( 19)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 19892 | 58 |
| LEAPCHEM CO., LTD. | +86-852-30606658 | market18@leapchem.com | China | 43348 | 58 |
| SPIRO PHARMA | eric_feng1954@126.com | China | 316 | 55 | |
| Shanghai EFE Biological Technology Co., Ltd. | 021-65675885 18964387627 | info@efebio.com | China | 9806 | 58 |
| ShangHai Biochempartner Co.,Ltd | 17754423994 17754423994 | 2853530910@QQ.com | China | 8014 | 62 |
| Fan De(Beijing) Biotechnology Co., Ltd. | 15911056312 | liming@bio-fount.com | China | 9730 | 58 |
| Guangzhou Hongyuan Chemical Co.,Ltd | 15817493340 | 981810490@qq.com | China | 1565 | 58 |
| Wuhan Chemstan Biotechnology Co., Ltd. | 027-65317797 15926423062 | 422450190@qq.com | China | 10351 | 58 |
| Abmole Bioscience Inc. | 021-50967598 02150967598 | sales@abmole.cn | China | 4495 | 58 |
| Bide Pharmatech Ltd. | 400-1647117 13681763483 | product02@bidepharm.com | China | 62163 | 58 |
Durvalumab
MEDI4736
Research Grade Durvalumab(DHJ70102)
1428935-60-7